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Automated solid-phase concatenation of Aib
residues to form long, water-soluble, helical
peptides†
Francis Zieleniewski, a Derek N. Woolfson *abc and Jonathan Clayden *a
Iterative coupling of 2-aminoisobutyric acid (Aib) has been achieved
rapidly and efficiently using automated solid-phase peptide synth-
esis, employing diisopropylcarbodiimide (DIC) in the presence of
ethyl cyanohydroxyiminoacetate (Oxyma). This method has allowed
the first total synthesis of the fungal antibiotic Cephaibol D, and
enabled the synthesis of water-soluble oligomers of Aib containing
up to an unprecedented sequence of 17 consecutive Aib residues.
Conformational analysis of the Aib oligomers in aqueous solution
shows a length dependence in their CD spectra, with oligomers of
more than 14 Aib residues apparently adopting structured helical
conformations.
De novo protein design using both rational and computational
approaches allows a wide range a novel peptide structures to be
explored.1,2 a-Helices have been widely used as design compo-
nents of these novel proteins.3,4 However, the 310 helix, an
analogue of the a-helix with only three residues per turn and
also found in natural protein structures, has gained signifi-
cantly less attention.5 A general strategy for incorporating
long 310-helical modules into artificial proteins would advance
de novo protein design, allowing use of a new secondary
structure in synthetic proteins.
The extended 310-helical conformation is commonly adopted
by peptides with a high density of a,a-disubstituted amino acids,6
the simplest of which is aminoisobutyric acid (Aib, abbreviated
here as U).7 However, these 310 helices tend to collapse towards
a-helical conformations in more polar solvents,8 and while the
conformational properties of Aib oligomers have been studied in
organic solvents9,10 and membranes,11 it is not clear whether
long Aib-rich structures can be maintained in water. Indeed,
there are few reported examples of water-soluble 310 helices.
The gp41659–671 peptide adopts a 310 helix in water, and, remark-
ably, it is made up entirely of proteinogenic amino acids.12
Toniolo and co-workers report a water-soluble Aib-rich 310 helix
with (L)-2-amino-3[1-(1,4,7-triazacyclononane)]propanoic acid
residues placed three residues apart to allow aqueous
solvation,13 but this peptide is only 7 residues in length.
Here, we show that it is possible to form long oligomers of
Aib (up to 17 consecutive residues) that are soluble in water.
To achieve this, we developed conditions that allow iterative
successive coupling of hindered a,a-disubstituted amino acids
on a solid-phase support. For the first time, this allows the
synthesis of long Aib-rich sequences by automated solid-phase
peptide synthesis (SPPS).
The conformational properties of Aib oligomers—typically
of 4–12 monomers—have been studied in non-aqueous sol-
vents by making use of an iterative solution-phase acylation-
reduction sequence.9 However, the standard technique for the
synthesis of natural and unnatural peptide sequences is SPPS,14
employing the base-labile Fmoc group to protect the a-amino
group of the growing peptide chain, and orthogonal acid-labile
peptide-resin linkages and side-chain protecting groups.15
Automation of SPPS16 has accelerated coupling–deprotection
cycles to the extent that each single-residue chain extension
may take as little as four minutes in microwave-equipped
instruments.17 Although these standard conditions work well
with proteinogenic and other a-amino acids, they give poor
yields with sterically hindered a,a-disubstituted amino acids
such as Aib.
Nonetheless, successive Aib residues may be coupled to a
peptide chain using SPPS much more rapidly than in solution.7
Hara and co-workers report the use of 3-nitro-1,2,4-triazol-1-
yltris(pyrrolidin-1-yl)phosphonium hexafluorophosphate (PyNTP)
to couple up to 10 successive Aib residues in high yield with
a coupling time of only 20 minutes at room temperature.18
The drawback of this approach is that 20 equivalents of PyNTP
and of base are required. Also, the expense and instability of
a School of Chemistry, University of Bristol, Cantock’s Close, Bristol, BS8 1TS, UK.
E-mail: D.N.Woolfson@bristol.ac.uk, j.clayden@bristol.ac.uk
b School of Biochemistry, University of Bristol, Medical Sciences Building,
University Walk, Bristol, BS8 1TS, UK
c Bristol BioDesign Institute, University of Bristol, Life Sciences Building,
Tyndall Avenue, Bristol BS8 1TQ, UK
† Electronic supplementary information (ESI) available: Peptide synthesis,
peptide purification, circular dichroism spectroscopy and analytical data. See
DOI: 10.1039/d0cc04698a
Received 7th July 2020,
Accepted 2nd September 2020
DOI: 10.1039/d0cc04698a
rsc.li/chemcomm
ChemComm
COMMUNICATION
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
2 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/1
1/
20
20
 5
:1
6:
53
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal
Chem. Commun. This journal is©The Royal Society of Chemistry 2020
phosphonium and uronium salts makes them less attractive for
routine use in automated synthesis.
A more-appealing approach to Aib couplings employs ethyl
cyanohydroxyiminoacetate (Oxyma). Initially reported in the
1970s as a way to reduce epimerisation,19 this weakly acidic
oxime has been applied in conjunction with DIC to enable
difficult couplings on a solid support by Albericio and
coworkers.20 Oxyma allows two consecutive Aib residues to be
coupled using DIC more efficiently than with common HOAt
and HOBt additives. Oxyma is also stable in DMF and does not
cap the resin prematurely during synthesis; two factors that
favour its utility in automated SPPS. A variety of oxonium and
phosphonium coupling reagents based on Oxyma have been
reported, such as COMU and PyOxim.21
The combination of DIC with Oxyma has found use in
microwave-assisted automated SPPS,17 and Oxyma’s superiority
as an activating additive has been demonstrated for coupling
two successive Aib residues during the synthesis of the peptai-
bols alamethicin and bergofungin.22 Using two equivalents of
DIC relative to the amino acid (or 10 equivalents relative to the
resin loading) significantly increases peptide purity,23 by
increasing the rate of formation of O-acylurea, accelerating
the activation of the amino acid. The use of DIC + Oxyma is
generally considered the method of choice for difficult peptide
couplings using microwave assisted automated SPPS.24
Using DIC + Oxyma as the coupling method, we explored the
types of water-soluble Aib-rich sequences that could be made by
automated SPPS. To validate the method for making Aib-rich
structures, we targeted Cephaibol D (1, Fig. 1),25 a 15-residue
peptaibol containing eight Aib (U) and two hydroxyproline (O)
residues. A partial synthesis of this molecule has been
reported26 but not a total synthesis. The Aib residues occur as
a synthetically challenging group of four consecutive residues, a
pair of consecutive Aib residues followed by hydroxyproline
(UUO), and a UOUP motif towards the C terminus.
Starting from preloaded Fmoc-phenylalaninol o-chlorotrityl
resin (0.44 mmol g1) and using Fmoc protection of the
N terminus, 1 was synthesised on a 0.1 mmol scale using
5 equivalents of amino acid and Oxyma and 10 equivalents of
DIC in each coupling cycle. The optimum conditions for
coupling were irradiation at 90 1C for 3 min with standard
amino acids, or at 100 1C for 10 min with Pro, Hyp, Aib and
any amino acid required to couple to an N-terminal Aib. Each
Fmoc deprotection was achieved using a 20% solution of
morpholine in DMF with formation of the morpholine-
fulvene adduct monitored by UV absorption at 301 nm to
estimate coupling efficacy (see ESI†). On completion of the
synthesis, the N terminus of the peptide was acetylated on the
resin with a solution of acetic anhydride and DIPEA in DMF for
30 min. The peptide was cleaved from the resin and depro-
tected in dilute TFA to prevent cleavage of Aib-Pro bond.22
This approach gave Cephaibol D 1 in just over 5.5 h with
high crude purity (Table 1), as determined by HPLC (Fig. 2).
Purification by semipreparative HPLC gave 1 in 26% yield over
15 coupling and deprotection steps.
This successful first total synthesis of Cephaibol D demon-
strates that multiple Aib-on-Aib couplings are possible in high
yield using SPPS without recourse to large excesses of phos-
phonium salts. On this basis, we designed longer sequences
containing consecutive Aib residues and maintaining water
solubility to allow purification by reverse-phase HPLC.
The extended Aib-rich sequences 2 and 3 are similar to the
Aib-rich 310 helices studied in organic solvents.
9,26 However, to
facilitate solubility in water, they incorporate a 7-residue cationic
tag, KKKKGYG. The tag was positioned at the N terminus of the
Fig. 1 (a) Sequences of Cephaibol D 1 and other peptides synthesised
(2–7). (b) Displayed structure of 3. Key: U, Aib; O, Hyp; Fol, phenylalaninol.
Table 1 Analysis and purity of synthesised peptides
Product
Synthesis time
(h :min)
Crude
purity (%)
Isolated
yield (%)
1 5 : 37 40 26
2 8 : 22 67 41
3 8 : 19 59 21
4 8 : 03 61 19
5 7 : 01 61 33
6 6 : 19 75 52
7 5 : 10 74 55
Fig. 2 HPLC profile of crude Cephaibol D 1 (detection at 220 nm).
The peak at 22 min was identified as Cephaibol D by MALDI-TOF mass
spectrometry.
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peptide to avoid interference with the folding of the Aib-rich
segment and incorporated a glycine-flanked27 chromophore to
allow the aqueous concentration to be quantified.
As Aib is achiral, its oligomers populate equally pairs of
enantiomeric confomers.28 Therefore, observation of conforma-
tion by circular dichroism (CD) spectroscopy requires at least
one chiral residue to induce a screw-sense preference. The 6-fold
UUA repeat of 2 incorporates a high density of chiral residues to
induce a screw sense preference. Nonetheless, the screw sense of
an Aib oligomer can be propagated from a single chiral
residue.29 Therefore, we made 3, which is identical in length to
2 but with a single Ala residue adjacent to 17 consecutive Aib
residues. Control peptide 4, lacking the Ala residue, was made to
verify the conformational influence of the cationic tag. 2, 3 and 4
were synthesised using the same conditions as 1, replacing
Fmoc-phenylalaninol o-chlorotrityl resin with rink amide MHBA
resin, and using more powerfully acidic conditions for resin
cleavage and side-chain deprotection (see ESI†). All three pep-
tides were synthesised in just over 8 hours with acceptable crude
purities and isolated yields (Table 1).
The water-soluble peptides 2 and 3 allowed the first ever
observation of the CD spectrum of Aib oligopeptides in aqueous
solution (100 mM, PBS buffer). CD spectra of 2 and 3 (Fig. 3a)
resembled spectra of Aib oligomers in organic solvents,9 with a
negative signal at 205 nm (indicating a right-handed screw sense
preference) and a positive maximum at 225 nm.30 The more-
intense CD signal of 2 can be attributed to the greater density of
Ala residues, giving 2 a greater average screw-sense preference
than 3. Nonetheless, the comparable magnitude of their CD
signals suggests that a substantial proportion of 3 adopts a right-
handed screw sense, induced from the C terminus (Fig. 1b).9d
Peptide 4 had no signal in the range 210–260 nm, confirming that
the cationic tag does not induce a screw-sense preference.
Previous data recorded in organic solvents suggest that the
stability of the helical conformation adopted by oligomers rich
in a,a-disubstituted amino acids is length dependent.31,32
Therefore, we synthesised 5, 6 & 7, shorter homologues of 3
with 14, 11 and 8 consecutive Aib residues, respectively. 6 and 7
showed no evidence of folding, despite their C-terminal L-Ala
residue (Fig. 3b), suggesting that oligomers of fewer than 11 Aib
residues do not form stable helices in water.
Peptide 5, with 14 Aib residues, behaved quite differently to
the others. Immediately after dissolving in PBS buffer, its CD
spectrum matched closely that of 3, suggesting that a 14-mer of
Aib may adopt a structured conformation in water. However,
over a period of minutes at room temperature, the CD curve
changed to one characteristic of a random coil (Fig. S1, ESI†).
Further exploration of the details of the structure adopted by
amphipathic peptides 2, 3 and 5, and of the conformational
transition of 5 in water, is under way.
In summary, long chains of Aib residues can be synthesised
rapidly and in high yield by automated SPPS using DIC with an
Oxyma coupling cocktail. This method has allowed the first
total synthesis of Cephaibol D. The coupling of 17 consecutive
Aib residues has been achieved in only 8 hours, which is much
more rapid than alternative methods. Capping the Aib oligo-
mers with a cationic tag makes them water-soluble, and these
water-soluble Aib oligopeptides show CD spectra similar to
those seen in organic solvents. We anticipate that this work
will be of value in the de novo design, synthesis and character-
isation of both water-soluble and membrane-active helical
peptides built from non-proteinogenic residues.
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